Early increase in arterial lactate concentration under epinephrine infusion is associated with a better prognosis during shock

Shock

Volumn 34, Issue 1, 2010, Pages 4-9

  Wutrich, Yann ^a   Barraud, Damien ^a   Conrad, Marie ^a   Cravoisy Popovic, Aurélie ^a   Nace, Lionel ^a   Bollaert, Pierre Edouard ^a   Levy, Bruno ^a,b   Gibot, Sébastien ^a,b  

^a CHU NANCY BRABOIS   (France)

^b INSERM   (France)

Author keywords

epinephrine; lactate; Shock

Indexed keywords

ADRENALIN; LACTIC ACID;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL INDICATOR; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FRANCE; HEMORRHAGIC SHOCK; HUMAN; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK; SURVIVOR; TEACHING HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; EPINEPHRINE; FEMALE; HUMANS; INFUSION PUMPS; INTENSIVE CARE UNITS; LACTIC ACID; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SHOCK; SYMPATHOMIMETICS;

EID: 77953887325     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ce2d23     Document Type: Article

References (25)

1. Cohen RD, Woods HF: Lactic acidosis revisited. Diabetes 32:181-191, 1983.
2. James JH, Fang CH, Schrantz SJ, Hasselgren PO, Paul RJ, Fischer JE: Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis. J Clin Invest 98:2388-2397, 1996.
3. James JH, Luchette FA, McCarter FD, Fischer JE: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 354:505-508, 1999.
4. James JH, Wagner KR, King JK, Leffler RE, Upputuri RK, Balasubramaniam A, Friend LA, Shelly DA, Paul RJ, Fischer JE: Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol 277:E176YE186, 1999.
5. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE: Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 365:871-875, 2005.
6. Levy B: Lactate and shock state: the metabolic view. Curr Opin Crit Care 12: 315-321, 2006.
7. Levy B, Desebbe O, Montemont C, Gibot S: Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 30:417-421, 2008.
8. Collin S, Sennoun N, Levy B: Cardiovascular and metabolic responses to catecholamine and sepsis prognosis: a ubiquitous phenomenon? Crit Care 12:118, 2008.
9. McCabe WR, Jackson GG: Gram negative bacteremia: I. Etiology and ecology. Arch Intern Med 110:845-847, 1962.
10. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A: Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 28:114-119, 2000.
11. Vincent JL: End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or..? Intensive Care Med 22:3-5, 2000.
12. Kompanje EJ, Jansen TC, van der Hoven B, Bakker J: The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814 Y 1869) in January 1843. Intensive Care Med 33:1967-1971, 2007.
13. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
14. Levraut J, Ichai C, Petit I, Ciebiera JP, Perus O, Grimaud D: Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med 31:705-710, 2003.
15. Liggett SB, Shah SD, Cryer PE: Characterization of beta-adrenergic receptors of human skeletal muscle obtained by needle biopsy. Am J Physiol 254: E795-E798, 1988.
16. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23:282-287, 1997.
17. Vallet B, Chopin C, Curtis SE, Dupuis BA, Fourrier F, Mehdaoui H, LeRoy B, Rime A, Santre C, Herbecq P, et al.: Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study. Crit Care Med 21:1868-1875, 1993.
18. Rhodes A, Lamb FJ, Malagon I, Newman PJ, Grounds RM, Bennett ED: A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock. Crit Care Med 27:2361-2366, 1999.
19. Levy B, Dusang B, Annane D, Gibot S, College Interregional des Réanimateurs du Nord-Est: Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med 33: 2172-2177, 2005.
20. Tappy L, Chiolero R: Substrate utilization in sepsis and multiple organ failure. Crit Care Med 35:S531-S534, 2007.
21. Singer M, De Santis V, Vitale D, Jeffcoate W: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:545-548, 2004.
22. Leverve XM: Mitochondrial function and substrate availability. Crit Care Med 35:S454-S460, 2007.
23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17-60, 2008.
24. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, CAT Study investigators: A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226-2234, 2008.
25. Annane D, Vignon P, Regnault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, et al.: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomized trial. Lancet 370:676-684, 2007.